Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Precancerous Conditions

1-anilino-8-naphthalenesulfonate has been researched along with Precancerous Conditions in 1 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research Excerpts

ExcerptRelevanceReference
"Orlistat is an anti-obesity agent that increases the fecal fat excretion, which promotes colon carcinogenesis."1.33The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen. ( Barros, LT; Garcia, SB; Martinello, F; Modiano, P; Ribeiro-Silva, A; Turatti, A; Uyemura, SA; VespĂșcio, MV, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garcia, SB1
Barros, LT1
Turatti, A1
Martinello, F1
Modiano, P1
Ribeiro-Silva, A1
VespĂșcio, MV1
Uyemura, SA1

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Precancerous Conditions

ArticleYear
The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen.
    Cancer letters, 2006, Aug-28, Volume: 240, Issue:2

    Topics: 1,2-Dimethylhydrazine; Animals; Anti-Obesity Agents; Carcinogens; Cell Proliferation; Colonic Neopla

2006